2021 Q1 Form 10-Q Financial Statement

#000143774921012445 Filed on May 17, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $1.490M $415.3K
YoY Change 258.74% 83.46%
Cost Of Revenue $395.8K $170.4K
YoY Change 132.33% 5.6%
Gross Profit $1.094M $244.9K
YoY Change 346.67% 276.59%
Gross Profit Margin 73.43% 58.98%
Selling, General & Admin $814.0K $437.8K
YoY Change 85.93% 47.29%
% of Gross Profit 74.41% 178.76%
Research & Development $130.4K $34.33K
YoY Change 279.94% 56.21%
% of Gross Profit 11.92% 14.02%
Depreciation & Amortization $4.324K $3.491K
YoY Change 23.86% -33.29%
% of Gross Profit 0.4% 1.43%
Operating Expenses $948.8K $475.6K
YoY Change 99.48% 86.44%
Operating Profit $145.1K -$230.7K
YoY Change -162.91% 21.39%
Interest Expense -$132.6K $516.1K
YoY Change -125.69% -2898.64%
% of Operating Profit -91.35%
Other Income/Expense, Net -$132.6K -$242.5K
YoY Change -45.34%
Pretax Income $12.56K $42.83K
YoY Change -70.69% -120.54%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $12.56K $42.83K
YoY Change -70.69% -120.54%
Net Earnings / Revenue 0.84% 10.31%
Basic Earnings Per Share $0.00 $0.01
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 8.514M 7.943M
Diluted Shares Outstanding 13.78M 13.56M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.114M $74.97K
YoY Change 1386.55% 204.14%
Cash & Equivalents $1.114M $74.97K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $18.02K
Prepaid Expenses
Receivables $11.00K $3.879K
Other Receivables $0.00 $1.870K
Total Short-Term Assets $1.143M $80.72K
YoY Change 1316.64% -54.06%
LONG-TERM ASSETS
Property, Plant & Equipment $317.8K $110.2K
YoY Change 188.26% -39.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $65.74K $117.6K
YoY Change -44.08%
Total Long-Term Assets $383.5K $227.8K
YoY Change 68.35% 25.71%
TOTAL ASSETS
Total Short-Term Assets $1.143M $80.72K
Total Long-Term Assets $383.5K $227.8K
Total Assets $1.527M $308.5K
YoY Change 394.94% -13.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $364.5K $639.6K
YoY Change -43.0% 5.89%
Accrued Expenses $67.96K $136.5K
YoY Change -50.2% -25.36%
Deferred Revenue
YoY Change
Short-Term Debt $284.1K $1.108M
YoY Change -74.35% 139.16%
Long-Term Debt Due $294.1K
YoY Change
Total Short-Term Liabilities $1.822M $3.448M
YoY Change -47.17% 116.32%
LONG-TERM LIABILITIES
Long-Term Debt $903.5K $0.00
YoY Change
Other Long-Term Liabilities $229.1K $55.95K
YoY Change 309.53% -48.18%
Total Long-Term Liabilities $1.133M $55.95K
YoY Change 1924.28% -48.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.822M $3.448M
Total Long-Term Liabilities $1.133M $55.95K
Total Liabilities $2.954M $3.504M
YoY Change -15.69% 105.89%
SHAREHOLDERS EQUITY
Retained Earnings -$7.172M -$6.787M
YoY Change 5.68%
Common Stock $8.580K $7.958K
YoY Change 7.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.427M -$3.195M
YoY Change
Total Liabilities & Shareholders Equity $1.527M $308.5K
YoY Change 394.94% -13.56%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $12.56K $42.83K
YoY Change -70.69% -120.54%
Depreciation, Depletion And Amortization $4.324K $3.491K
YoY Change 23.86% -33.29%
Cash From Operating Activities $231.9K -$40.28K
YoY Change -675.81% -61.68%
INVESTING ACTIVITIES
Capital Expenditures $31.23K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$31.23K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $150.5K $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$59.04K 94.07K
YoY Change -162.75% -7.54%
NET CHANGE
Cash From Operating Activities $231.9K -40.28K
Cash From Investing Activities -$31.23K
Cash From Financing Activities -$59.04K 94.07K
Net Change In Cash $141.6K 53.80K
YoY Change 163.29% -1705.43%
FREE CASH FLOW
Cash From Operating Activities $231.9K -$40.28K
Capital Expenditures $31.23K
Free Cash Flow $200.7K -$40.28K
YoY Change -598.26% -61.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 blbx Amortization Of Note Discount Premium
AmortizationOfNoteDiscountPremium
91539
CY2020Q1 blbx Amortization Of Note Discount Premium
AmortizationOfNoteDiscountPremium
51607
CY2020 blbx Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
115385
CY2020 blbx Class Of Warrant Or Right Exercised In Period Price Per Share
ClassOfWarrantOrRightExercisedInPeriodPricePerShare
0.01
CY2020 blbx Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
CY2021Q1 blbx Conversion Of Convertible Liability Shares Issued
ConversionOfConvertibleLiabilitySharesIssued
92308
CY2021Q1 blbx Convertible Liability Conversion Price
ConvertibleLiabilityConversionPrice
1.95
CY2021Q1 blbx Convertible Liability Original Amount
ConvertibleLiabilityOriginalAmount
180000
CY2021Q1 blbx Convertible Note Default Expense
ConvertibleNoteDefaultExpense
CY2020Q1 blbx Convertible Note Default Expense
ConvertibleNoteDefaultExpense
24750
CY2021Q1 blbx Convertible Note Financing Expense
ConvertibleNoteFinancingExpense
CY2020Q1 blbx Convertible Note Financing Expense
ConvertibleNoteFinancingExpense
217776
CY2021Q1 blbx Expenses Paid By Lender
ExpensesPaidByLender
CY2020Q1 blbx Expenses Paid By Lender
ExpensesPaidByLender
6133
CY2021Q1 blbx Increase Decrease In Interest Payable Related Party
IncreaseDecreaseInInterestPayableRelatedParty
CY2020Q1 blbx Increase Decrease In Interest Payable Related Party
IncreaseDecreaseInInterestPayableRelatedParty
3640
CY2021Q1 blbx Issuance Of Stock In Settlement Of Financing Costs
IssuanceOfStockInSettlementOfFinancingCosts
CY2020Q1 blbx Issuance Of Stock In Settlement Of Financing Costs
IssuanceOfStockInSettlementOfFinancingCosts
100000
CY2021Q1 blbx Lease Liability Current
LeaseLiabilityCurrent
59918
CY2020Q4 blbx Lease Liability Current
LeaseLiabilityCurrent
40473
CY2021Q1 blbx Lease Liability Noncurrent
LeaseLiabilityNoncurrent
229125
CY2020Q4 blbx Lease Liability Noncurrent
LeaseLiabilityNoncurrent
26241
CY2021Q1 blbx Lease Right Of Use Asset Accumulated Amortization
LeaseRightOfUseAssetAccumulatedAmortization
107987
CY2020Q4 blbx Lease Right Of Use Asset Accumulated Amortization
LeaseRightOfUseAssetAccumulatedAmortization
97725
CY2021Q1 blbx Lease Rightofuse Asset
LeaseRightofuseAsset
285184
CY2020Q4 blbx Lease Rightofuse Asset
LeaseRightofuseAsset
62348
CY2021Q1 blbx Noncash Portion Of Lease Expense
NoncashPortionOfLeaseExpense
-506
CY2020Q1 blbx Noncash Portion Of Lease Expense
NoncashPortionOfLeaseExpense
CY2021Q1 blbx Nonconvertible Notes Payable Current
NonconvertibleNotesPayableCurrent
130773
CY2020Q4 blbx Nonconvertible Notes Payable Current
NonconvertibleNotesPayableCurrent
131605
CY2021Q1 blbx Note Payable Related Party Exchanged For Advances
NotePayableRelatedPartyExchangedForAdvances
CY2020Q1 blbx Note Payable Related Party Exchanged For Advances
NotePayableRelatedPartyExchangedForAdvances
2954
CY2021Q1 blbx Notes Payable Exchanged With Note Payable
NotesPayableExchangedWithNotePayable
CY2020Q1 blbx Notes Payable Exchanged With Note Payable
NotesPayableExchangedWithNotePayable
39370
CY2021Q1 blbx Prepaid Expenses Related Party Noncurrent
PrepaidExpensesRelatedPartyNoncurrent
36700
CY2020Q4 blbx Prepaid Expenses Related Party Noncurrent
PrepaidExpensesRelatedPartyNoncurrent
36700
CY2021Q1 blbx Proceeds From Subscription Of Common Stock
ProceedsFromSubscriptionOfCommonStock
-12500
CY2020Q1 blbx Proceeds From Subscription Of Common Stock
ProceedsFromSubscriptionOfCommonStock
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
68589
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
68589
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
91539
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
51607
CY2021Q1 blbx Property Plant And Equipment Right Of Use Lease Assets And Finited Lived Intangible Assets
PropertyPlantAndEquipmentRightOfUseLeaseAssetsAndFinitedLivedIntangibleAssets
317776
CY2020Q4 blbx Property Plant And Equipment Right Of Use Lease Assets And Finited Lived Intangible Assets
PropertyPlantAndEquipmentRightOfUseLeaseAssetsAndFinitedLivedIntangibleAssets
68030
CY2021Q1 blbx Repayments Of Convertible Note Payable
RepaymentsOfConvertibleNotePayable
196209
CY2020Q1 blbx Repayments Of Convertible Note Payable
RepaymentsOfConvertibleNotePayable
CY2021Q1 blbx Repayments Of Notes Payable Related Parties
RepaymentsOfNotesPayableRelatedParties
CY2020Q1 blbx Repayments Of Notes Payable Related Parties
RepaymentsOfNotesPayableRelatedParties
27046
CY2020Q4 blbx Repayments Of Trade Payables
RepaymentsOfTradePayables
133880
CY2021Q1 blbx Shortterm And Longterm Debt Gross
ShorttermAndLongtermDebtGross
1386840
CY2020Q4 blbx Shortterm And Longterm Debt Gross
ShorttermAndLongtermDebtGross
1583881
CY2021Q1 blbx Stock Issued During Period Shares Previously Subscribed Shares
StockIssuedDuringPeriodSharesPreviouslySubscribedShares
6411
CY2021Q1 blbx Stock Issued During Period Value Previously Subscribed Shares
StockIssuedDuringPeriodValuePreviouslySubscribedShares
CY2020Q1 blbx Stock Issued During Period Value Settlement Of Accrued Expenses
StockIssuedDuringPeriodValueSettlementOfAccruedExpenses
100000
CY2021Q1 blbx Stock Issued During Period Value Settlement Of Liabilities
StockIssuedDuringPeriodValueSettlementOfLiabilities
180000
CY2021Q1 blbx Stock Issued Settlement Of Accrued Liabilities
StockIssuedSettlementOfAccruedLiabilities
180000
CY2020Q1 blbx Stock Issued Settlement Of Accrued Liabilities
StockIssuedSettlementOfAccruedLiabilities
CY2019 blbx Warrants And Rights Outstanding Remaining Term
WarrantsAndRightsOutstandingRemainingTerm
P4Y193D
CY2021Q1 blbx Warrants And Rights Outstanding Remaining Term
WarrantsAndRightsOutstandingRemainingTerm
P3Y313D
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8579877
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
364544
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
352545
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10996
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17990
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5731490
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5401154
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
13314
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
CY2021Q1 us-gaap Assets
Assets
1526999
CY2020Q4 us-gaap Assets
Assets
1157849
CY2021Q1 us-gaap Assets Current
AssetsCurrent
1143480
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1008476
CY2021Q1 us-gaap Cash
Cash
1114468
CY2020Q4 us-gaap Cash
Cash
972825
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
972825
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21172
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1114468
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
74970
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
141643
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
53798
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.95
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.97
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.97
CY2021Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
479554
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
84295
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
479554
CY2021Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
479554
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8579877
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8410386
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8579877
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8410386
CY2021Q1 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
CY2020Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
12500
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
8580
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
8410
CY2021Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
152481
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
257150
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
395775
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
170352
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
189265
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
294119
CY2021Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1197575
CY2020Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1289762
CY2021Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
86538
CY2020Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
99852
CY2021Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1094993
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1016157
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4324
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3491
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4324
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3491
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2021Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
CY2020Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
601170
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
606687
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
349446
CY2021Q1 us-gaap Gross Profit
GrossProfit
1093893
CY2020Q1 us-gaap Gross Profit
GrossProfit
244899
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12555
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
42829
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11999
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7284
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6994
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1866
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
78836
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
73084
CY2021Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-2388
CY2020Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
28434
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
355
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-15600
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
CY2021Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
41038
CY2020Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
33495
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
43425
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
CY2021Q1 us-gaap Interest Payable Current
InterestPayableCurrent
8037
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
10425
CY2021Q1 us-gaap Inventory Net
InventoryNet
18016
CY2020Q4 us-gaap Inventory Net
InventoryNet
17661
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1526999
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1157849
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1821605
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1999214
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1132587
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
916389
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
294113
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
399614
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
903462
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
890148
CY2021Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
207312
CY2020Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
88344
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-59035
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
94074
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31234
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
231912
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40276
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-354911
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-2983438
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12555
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
42829
CY2021Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
859
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
859
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
948761
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
475612
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
145132
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-230713
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
180000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31234
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
65743
CY2020Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
81343
CY2021Q1 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
29043
CY2020Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
44643
CY2021Q1 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
130438
CY2020Q1 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
34331
CY2020Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
110980
CY2021Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Reclassification</div> - Affiliate referral expenses totaling $ <div style="display: inline; font-style: italic; font: inherit;">37,496</div> as of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>have been reclassed from cost of operations to selling, general and administrative expenses on the statement of operations.</div></div></div></div></div>
CY2021Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
CY2020Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
100000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
150506
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
CY2020Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
127100
CY2021Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2020Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5000
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
832
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7172263
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7184818
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1489668
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
415251
CY2021Q1 us-gaap Senior Long Term Notes
SeniorLongTermNotes
903462
CY2020Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
890148
CY2021Q1 us-gaap Senior Notes Current
SeniorNotesCurrent
10000
CY2020Q4 us-gaap Senior Notes Current
SeniorNotesCurrent
10000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
138006
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1427193
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1757754
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-3338299
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-3195470
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Use of Estimates</div> - The Company's financial statement preparation requires that management make estimates and assumptions which affect the reporting of assets and liabilities and the related disclosure of contingent assets and liabilities in order to report these financial statements in conformity with GAAP.&nbsp;&nbsp;Actual results could differ from those estimates.</div></div></div></div></div>
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14134194
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13555627
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8513694
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7942846

Files In Submission

Name View Source Status
0001437749-21-012445-index-headers.html Edgar Link pending
0001437749-21-012445-index.html Edgar Link pending
0001437749-21-012445.txt Edgar Link pending
0001437749-21-012445-xbrl.zip Edgar Link pending
blbx-20210331.xml Edgar Link completed
blbx-20210331.xsd Edgar Link pending
blbx-20210331_cal.xml Edgar Link unprocessable
blbx-20210331_def.xml Edgar Link unprocessable
blbx-20210331_lab.xml Edgar Link unprocessable
blbx-20210331_pre.xml Edgar Link unprocessable
blkbx20210331_10q.htm Edgar Link pending
ex_249639.htm Edgar Link pending
ex_249640.htm Edgar Link pending
ex_249641.htm Edgar Link pending
ex_249642.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending